SLTM  Solta Medical Inc

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

235.8M

Vuru Grade

22.38/100

Current Price

$2.92
0.00 (0.00%)

Growth Price

$2.04
Overvalued by 30.20%

Stability Price

$0.56
Overvalued by 80.81%

Company Metrics

  • 162.22 P/E
  • 1.56 P/S
  • 1.71 P/B
  • 0 EPS
  • 14.17% Cash ROIC
  • 0.51 Cash Ratio
  • 0 / 0% Dividend
  • 1.50M Avg. Vol.
  • 60.57M Shares
  • 235.8M Market Cap.

Company Description

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin con...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

A High Growth Area for Health Care Investors That Isn't Biotech
Equities.com - Aug 26, 2014
WP: There are a couple of technologies that compete today. In the ultrasound space, there is Valeant Pharmaceuticals International Inc. (VRX) ($VRX:CA), which now owns Solta Medical Inc. and its LipoSonix technology. Additionally, Syneron Medical Ltd.
Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
Wall Street Journal - Jul 31, 2014
(b) ASC 805, accounting for business combinations requires an inventory fair value step-up whose total impact for the six months ended June 30, 2014 is $9.6 million primarily relating to the acquisition of Solta Medical, Inc. on January 23, 2014. For ...
Medtech Shifts From High Gear Into Overdrive: Canaccord's William Plovanic
Seeking Alpha (registration) - Aug 20, 2014
In the ultrasound space, there is Valeant Pharmaceuticals International Inc. (NYSE:VRX), which now owns Solta Medical Inc. and its LipoSonix technology.
Increasing Demand for Skin Resurfacing Treatments: US Fractional Laser ...
MarketWatch - Aug 25, 2014
This market is led by Solta Medical, which was recently acquired by Valeant for $236 million in quarter one of 2014. Solta Medical's Fraxel®, was a revolutionary fractional laser treatment to resurface the skin and address sun damage and unwanted ...
Valeant buys dermatology drugs from Valeo Pharma for $25M
CBC.ca - Aug 25, 2014
Valeant Canada's recent acquisitions include Dermik, Medicis, Obagi, Bausch & Lomb, Solta Medical and Pro-Derma. Valeant Pharmaceuticals is in the midst of a hostile takeover fight for U.S.
Discover important facts about the Asia-Pacific Aesthetic Lasers and Energy ...
WhaTech - Aug 24, 2014
The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy ...
Explore EU5 aesthetic lasers and energy devices market outlook to 2020
WhaTech - Aug 24, 2014
The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy ...
Bacterin Announces the Appointment of New Board Member
NASDAQ - Aug 13, 2014
13, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to ...
Skincare devices market hits $12799.5 million by 2020
WhaTech - Aug 19, 2014
The global market for skincare devices is expected to reach USD 12,799.5 million by 2020, growing at an estimated CAGR of 10.0% from 2014 to 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of skin disorders and skin ...
New Market Research Reports that the Skincare Devices Industry Expected to ...
PR.com (press release) - Aug 21, 2014
San Francisco, CA, August 21, 2014 --(PR.com)-- The global market for skincare devices is expected to reach USD 12,799.5 million by 2020, growing at an estimated CAGR of 10.0% from 2014 to 2020, according to a new study by Grand View Research, Inc.